Zentera Therapeutics Funding: $95M Raised, Series B (2021)
Zentera Therapeutics is based in Shanghai, China. It has raised $95M in total funding. Latest round: Series B.
Zentera Therapeutics funding overview
Zentera Therapeutics is based in Shanghai, China. Zentera Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for Zentera Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include OrbiMed Advisors Asia, Tybourne Capital Management, Avidity Partners, Casdin Capital. 4 distinct backers are named across the disclosed rounds.
Zentera Therapeutics at a glance
Total raised
$95M
Latest round
Series B
Latest round date
August 2021
Headquarters
Shanghai, China
Notable investors
OrbiMed Advisors Asia, Tybourne Capital Management, Avidity Partners, Casdin Capital
Frequently asked about Zentera Therapeutics funding
How much has Zentera Therapeutics raised?
Zentera Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Zentera Therapeutics?
OrbiMed Advisors Asia, Tybourne Capital Management, Avidity Partners, Casdin Capital are named among the investors backing Zentera Therapeutics.
What was the latest Zentera Therapeutics funding round?
The most recent disclosed round is a Series B, announced in August 2021.
Where is Zentera Therapeutics based?
Zentera Therapeutics is based in Shanghai, China.
When did Zentera Therapeutics last raise?
The last disclosed Zentera Therapeutics round closed in August 2021 at Series B.
Zentera Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
